Adaptimmune Therapeutics PLC (ADAPY) EBIT Margin (2015 - 2025)
Adaptimmune Therapeutics (ADAPY) posted EBIT Margin of -221.45% for Q2 2025, down 275.03 percentage points from 53.58% a year earlier but up 406.32 percentage points from the prior quarter.
Adaptimmune Therapeutics PLC (ADAPY) EBIT Margin (2015 - 2025) Analysis & Trends
For the trailing twelve months through Jun 30, 2025, EBIT Margin at Adaptimmune Therapeutics was -252.32%, down 197.85 percentage points year-over-year; for FY2024, it came in at -38.62%, up 193.19 percentage points from FY2023.
- Annual EBIT Margin has increased for five consecutive years, with a five-year change of +12418.60 percentage points (FY2019 to FY2024).
- In prior years, Adaptimmune Therapeutics' EBIT Margin was -231.82% in FY2023 (+372.15 pp), -603.97% in FY2022 (+2034.61 pp), -2638.58% in FY2021 (+731.94 pp) and -3370.52% in FY2020 (+9086.70 pp).
- Quarterly EBIT Margin has run from a low of -21582.68% in Q4 2023 to a high of 53.58% in Q2 2024 over five years.
- On a year-over-year basis, EBIT Margin increased in four of the last eight quarters, with an average year-over-year change of -179.30 percentage points.
- The strongest year-over-year quarter for EBIT Margin in the past five years was Q4 2024, with a gain of 19300.90 percentage points; the weakest was Q4 2023, with a drop of 21335.66 percentage points.
- According to Business Quant data, EBIT Margin for the three prior quarters was -627.77% (Q1 2025), -2281.78% (Q4 2024) and -35.89% (Q3 2024).
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | -221.45% |
| Mar 31, 2025 | -627.77% |
| Dec 31, 2024 | -2,281.78% |
| Sep 30, 2024 | -35.89% |
| Jun 30, 2024 | 53.58% |
| Mar 31, 2024 | -867.58% |
| Dec 31, 2023 | -21,582.68% |
| Sep 30, 2023 | -637.15% |
| Jun 30, 2023 | -875.40% |
| Mar 31, 2023 | 3.48% |
| Dec 31, 2022 | -247.03% |
| Sep 30, 2022 | -613.53% |
| Jun 30, 2022 | -790.03% |
| Mar 31, 2022 | -1,398.07% |
| Dec 31, 2021 | -3,024.98% |
| Sep 30, 2021 | -3,506.32% |
| Jun 30, 2021 | -1,270.18% |
| Mar 31, 2021 | -8,730.18% |
| Dec 31, 2020 | -2,497.54% |
| Sep 30, 2020 | -3,007.12% |
Adaptimmune Therapeutics PLC EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();